"$CFRX ContraFect Announces Publication on Exebacase and CF-296 Demonstrating Potent In Vivo Antimicrobial Activity in Implant-Associated MRSA Osteomyelitis https://t.co/nlUQfI8XII"

exebacase (CF-301) - ContraFect

Aug 15, 2022